Pharmacological therapy of bleeding, chronic radiation proctitis

MiFlaPro - multicentre phase III AMG study of chronic haemorrhagic radiation proctitis. The MiFlaPro study is a national, multicentre, double-blind randomised placebo-controlled study on the therapy of bleeding chronic radiation proctitis.

Further information:

• >> For patients (PDF download - in German)
• >> For medical personnal (PDF download - in German)
• >> For participating centre (Login required - Link to German website)

Contact:

Medical University of Innsbruck
Christopher Dawoud, MD - christopher.dawoud@meduniwien.ac.at
Marijana Ninkovic, MD - marijana.ninkovic@i-med.ac.at